Literature DB >> 8165977

Dynamic contrast-enhanced MR angiography of pulmonary embolism: comparison with pulmonary angiography.

P Loubeyre1, D Revel, P Douek, A Delignette, C Baldy, G Genin, M Amiel.   

Abstract

OBJECTIVE: Subsecond contrast-enhanced MR angiography, which is not a flow-based technique and does not require cardiac gating or breath-holding, provides multiplanar, rapid, dynamic visualization of the pulmonary arteries. Accordingly, we evaluated the use of this technique in the diagnosis of thrombi in both the proximal and peripheral portions of the pulmonary arteries. Digital subtraction angiography was used as the gold standard for the diagnosis. SUBJECTS AND METHODS: Twenty-three consecutive patients with suspected pulmonary embolism were included in the study. All patients had intraarterial digital subtraction angiography, which showed emboli in 12 patients (13 proximal and six peripheral emboli). MR angiography was done within 24 hr of digital subtraction angiography. Subsecond contrast-enhanced MR angiograms were obtained in the long axis of each pulmonary artery after a unique injection of contrast medium (0.1 mmol/kg) in an antecubital vein. Fifteen dynamic frames of each pulmonary artery were alternately obtained in less than 1 min. MR angiograms were interpreted by two observers who had no knowledge of the findings on digital subtraction angiography. A diagnosis of pulmonary emboli was made when MR angiograms showed a constant intraluminal filling defect or an abrupt vascular cutoff.
RESULTS: All thrombi in the proximal branches of the pulmonary arteries were visualized on MR angiograms (n = 13), whereas none of the thrombi in the distal part of the pulmonary arteries were seen (n = 6). In the 11 patients in whom no pulmonary emboli were shown by digital subtraction angiography, findings on MR angiograms were normal (sensitivity, 0.7; specificity, 1.0).
CONCLUSION: Our results suggest that dynamic contrast-enhanced MR angiography is an accurate method for detecting emboli in the proximal portions of the pulmonary arteries but is of no value in detecting peripheral emboli.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 8165977     DOI: 10.2214/ajr.162.5.8165977

Source DB:  PubMed          Journal:  AJR Am J Roentgenol        ISSN: 0361-803X            Impact factor:   3.959


  7 in total

1.  Evaluation of meglumine gadoterate-enhanced MR angiography (MRA) compared with time-of-flight MRA in the diagnosis of clinically significant non-coronary arterial disease: a pooled analysis of data from two clinical trials.

Authors:  D J Shah; T-H Lim
Journal:  Br J Radiol       Date:  2011-12-13       Impact factor: 3.039

Review 2.  MR imaging of the pulmonary vasculature--an update.

Authors:  Mark R Pedersen; Mark T Fisher; Edwin J R van Beek
Journal:  Eur Radiol       Date:  2006-01-04       Impact factor: 5.315

Review 3.  Systematic review and meta-analysis of strategies for the diagnosis of suspected pulmonary embolism.

Authors:  Pierre-Marie Roy; Isabelle Colombet; Pierre Durieux; Gilles Chatellier; Hervé Sors; Guy Meyer
Journal:  BMJ       Date:  2005-07-30

4.  MR Pulmonary angiography: assessment of PIOPED III data.

Authors:  Frank J Rybicki
Journal:  Int J Cardiovasc Imaging       Date:  2011-02-24       Impact factor: 2.357

5.  Gadolinium-enhanced magnetic resonance angiography for pulmonary embolism: a multicenter prospective study (PIOPED III).

Authors:  Paul D Stein; Thomas L Chenevert; Sarah E Fowler; Lawrence R Goodman; Alexander Gottschalk; Charles A Hales; Russell D Hull; Kathleen A Jablonski; Kenneth V Leeper; David P Naidich; Daniel J Sak; H Dirk Sostman; Victor F Tapson; John G Weg; Pamela K Woodard
Journal:  Ann Intern Med       Date:  2010-04-06       Impact factor: 25.391

6.  Factors in the technical quality of gadolinium enhanced magnetic resonance angiography for pulmonary embolism in PIOPED III.

Authors:  H Dirk Sostman; Kathleen A Jablonski; Pamela K Woodard; Paul D Stein; David P Naidich; Thomas L Chenevert; John G Weg; Charles A Hales; Russell D Hull; Lawrence R Goodman; Victor F Tapson
Journal:  Int J Cardiovasc Imaging       Date:  2011-02-24       Impact factor: 2.357

7.  Evaluation of contrast-enhanced magnetic resonance angiography (MRA) using Gd-DOTA compared with time-of-flight MRA in the diagnosis of clinically significant non-coronary arterial disease.

Authors:  Joon-Won Kang; Tae-Hwan Lim; Choong-Gon Choi; Gi-Young Ko; Jeong-Kon Kim; Tae-Won Kwon
Journal:  Eur Radiol       Date:  2010-04-21       Impact factor: 5.315

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.